Evidence map›Paper›PMID 36735908›Full record

ArticleBlood2023

Predictive value of staging PET/CT to detect bone marrow involvement and early outcomes in marginal zone lymphoma.

Juan Pablo Alderuccio, Isildinha M Reis, Jean L Koff, Melissa C Larson, Dai Chihara, Wei Zhao, Sara Haddadi, Thomas M Habermann, Peter Martin, Jennifer R Chapman and 7 more

Open access · greenAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Blood, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
3.3field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 10 institutions in 1 country.

Juan Pablo AlderuccioDivision of Hematology, Department of Medicine, Sylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine, Miami, FL.ORCID 0000-0002-2690-3377
Isildinha M ReisDepartment of Public Health Sciences, University of Miami Miller School of Medicine, Miami, FL.
Jean L KoffDepartment of Hematology and Medical Oncology, Winship Cancer Institute, Emory University School of Medicine, Atlanta, GA.ORCID 0000-0003-4414-0489
Melissa C LarsonDepartment of Quantitative Health Sciences, Mayo Clinic, Rochester, MN.
Dai ChiharaDepartment of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX.ORCID 0000-0002-1153-2294
Wei ZhaoBiostatistics and Bioinformatics Shared Resource, Sylvester Comprehensive Cancer Center, Miami, FL.
Sara HaddadiDivision of Hematology, Department of Medicine, Sylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine, Miami, FL.
Thomas M HabermannDivision of Hematology, Mayo Clinic, Rochester, MN.
Peter MartinDivision of Hematology/Oncology, Weill Cornell Medical College-New York Presbyterian Hospital, New York, NY.
Jennifer R ChapmanDepartment of Pathology and Laboratory Medicine, Sylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine, Miami, FL.
Christopher StrouseDivision of Hematology, Oncology, and Blood & Marrow Transplantation, University of Iowa, Iowa City, IA.
Brad S KahlDivision of Oncology, Washington University School of Medicine in St. Louis, St. Louis, MO.ORCID 0000-0003-0459-6609
Jonathon B CohenDepartment of Hematology and Medical Oncology, Winship Cancer Institute, Emory University School of Medicine, Atlanta, GA.ORCID 0000-0002-2723-6481
Jonathan W FriedbergDivision of Hematology/Oncology, University of Rochester, Rochester, NY.
James R CerhanDepartment of Quantitative Health Sciences, Mayo Clinic, Rochester, MN.ORCID 0000-0002-7482-178X
Christopher R FlowersDepartment of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX.
Izidore S LossosDivision of Hematology, Department of Medicine, Sylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine, Miami, FL.ORCID 0000-0002-9346-9013
University of Miami · USEmory University · USMayo Clinic in Florida · USThe University of Texas MD Anderson Cancer Center · USMayo Clinic · USNewYork–Presbyterian Hospital · USSylvester Comprehensive Cancer Center · USUniversity of Iowa · USUniversity of Rochester · USWashington University in St. Louis · US

Funding

Women's Cancer ProgramP30CA015083 · NCI · MAYO CLINIC ROCHESTER · PI Felicity Enders · 1985 to 2026
$151.3M
The Role of Monocytes in non-Hodgkin LymphomaP50CA097274 · NCI · UNIVERSITY OF IOWA · PI WEINER, GEORGE J. · 2002 to 2021
$45.7M
The Lymphoma Epidemiology of Outcomes (LEO) Cohort Study (Supplement)U01CA195568 · NCI · MAYO CLINIC ROCHESTER · PI CERHAN, JAMES R, FLOWERS, CHRISTOPHER R · 2015 to 2025
$22.1M
Identify the Mechanisms of LMO2-Mediated Inhibition of Homologous Recombination and Establish PARP-Targeted Synthetic Lethality as a New Therapy for DLBCLR01CA233945 · NCI · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI LOSSOS, IZIDORE S, VERDUN, RAMIRO ERNESTO · 2019 to 2023
$1.8M
NCI NIH HHS P30 CA015083NCI NIH HHS P50 CA097274NCI NIH HHS R01 CA233945NCI NIH HHS U01 CA195568
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Lymphoma, B-Cell, Marginal ZonePositron Emission Tomography Computed TomographyBiopsyBone MarrowFluorodeoxyglucose F18HumansNeoplasm StagingPositron-Emission TomographyRetrospective StudiesFluorodeoxyglucose F18

Identifiers

PMID36735908
PMCPMC10122102
OpenAlexW4319068348

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.